Assignee
EIL THERAPEUTICS INC
US·2 granted patents·3 pending applications·0 citations·filing 2022–2023
Top patents by PatentIndex Score
5 records- 0150US2024043424A1Compounds having ((3-nitrophenyl)sulfonyl)acetamide as bcl-2 inhibitorsEIL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0249US2025115577A1BCL-2 InhibitorsEIL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0349US2023357238A1Compounds having ((3-nitrophenyl)sulfonyl)acetamide as bcl-2 inhibitorsEIL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0445US11697650B2Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitorsEIL THERAPEUTICS INC·Filed 2022·Granted Jul 11, 2023·0 cites·61 claims
- 0543US11834450B2Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitorsEIL THERAPEUTICS INC·Filed 2022·Granted Dec 5, 2023·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when EIL THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →